Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials

被引：0
|
作者：
Laukhtina, E. [1 ]
Mori, K. [2 ]
Mostafaei, H. [2 ]
Merseburger, A. S. [3 ]
Nyirady, P. [4 ]
Moschini, M. [5 ]
Quhal, F. [2 ]
Pradere, B. [2 ]
Sari, Motlagh R. [2 ]
Schuettfort, V. M. [2 ]
Enikeev, D. [1 ]
Shariat, S. F. [2 ]
机构：
[1] Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
[2] Med Univ Vienna, Dept Urol, Vienna, Austria
[3] Univ Hosp Schleswig Holstein, Dept Urol, Lubeck, Germany
[4] Semmelweis Univ, Dept Urol, Budapest, Hungary
[5] Luzerner Kantonsspital, Dept Urol, Luzern, Switzerland
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0834
引用
收藏
页码：S1164 / S1165
页数：2
相关论文
共 50 条
  • [1] Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials
    Laukhtina, Ekaterina
    Mori, Keiichiro
    Mostafaei, Hadi
    Merseburger, Axel S.
    Nyirady, Peter
    Moschini, Marco
    Quhal, Fahad
    Pradere, Benjamin
    Motlagh, Reza Sari
    Enikeev, Dmitry
    Shariat, Shahrokh F.
    SEMINARS IN ONCOLOGY, 2021, 48 (03) : 181 - 192
  • [2] Different Chemotherapy Regimens in the Management of Advanced or Metastatic Urothelial Cancer: a Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Wang, Yi
    Xu, Lingyan
    Meng, Xianghu
    Qin, Zhiqiang
    Wang, Yamin
    Chen, Chen
    Wang, Yichun
    Zhou, Xiang
    Zhang, Qijie
    Xia, Jiadong
    Song, Ninghong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 50 (01) : 1 - 14
  • [3] Immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis of randomized controlled trials
    Fonseca Alves, Ana Caroline
    Mendes da Silva, Isadora Mamede
    Romero, Lorena Escalante
    Goncalves Celso, Davi Said
    Abrahao Reis, Pedro Cotta
    Dacoregio, Maria Inez
    Stecca, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Mamede, Isadora
    Escalante-Romero, Lorena
    Celso, Davi S. Goncalves
    Reis, Pedro C. Abrahao
    Dacoregio, Maria Inez
    Alves, Ana Caroline
    Stecca, Carlos
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
  • [5] ADVERSE EVENTS OF THE SECOND-LINE TREATMENT STRATEGIES FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA OF THE BLADDER: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Laukhtina, Ekaterina
    Mori, Keiichiro
    Mostafaei, Hadi
    Merseburger, Axel S.
    Nyirady, Peter
    Moschini, Marco
    Quhal, Fahad
    Pradere, Benjamin
    Motlagh, Reza Sari
    Schuettfort, Victor M.
    Enikeev, Dmitry
    Shariat, Shahrokh F.
    JOURNAL OF UROLOGY, 2021, 206 : E768 - E769
  • [6] Efficacy and safety of first-line immunotherapy-containing regimens compared with chemotherapy for advanced or metastatic urothelial carcinoma: a network meta-analysis of randomized controlled trials
    Liang, Weiming
    Huang, Shibo
    Huang, Yanping
    Huang, Miaoyan
    Li, Chunyan
    Liang, Yiwen
    Pang, Li
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [7] Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: A systematic review and network meta-analysis
    Mastrantoni, L.
    Beccia, V.
    Chiaravalli, M.
    Di Bello, A.
    Spring, A.
    Barone, D.
    Schietroma, F.
    Maratta, M. G.
    Trovato, G.
    Bagala, C.
    Bensi, M.
    Alfieri, S.
    Quero, G.
    Tortora, G.
    Salvatore, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S920 - S920
  • [8] Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer A network meta-analysis
    Qu, Chang-Ping
    Sun, Gui-Xia
    Yang, Shao-Qin
    Tian, Jun
    Si, Jin-Ge
    Wang, Yi-Feng
    MEDICINE, 2017, 96 (02)
  • [9] Systematic or Meta-analysis Studies Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis
    Martini, Alberto
    Raggi, Daniele
    Fallara, Giuseppe
    Nocera, Luigi
    Schultz, Julianne G.
    Belladelli, Federico
    Marandino, Laura
    Salonia, Andrea
    Briganti, Alberto
    Montorsi, Francesco
    Powles, Thomas
    Necchi, Andrea
    CANCER TREATMENT REVIEWS, 2022, 104
  • [10] Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer: a meta-analysis of randomized controlled trials
    Bogani, Giorgio
    Monk, Bradley J.
    Barretina-Ginesta, Maria-Pilar
    Raspagliesi, Francesco
    Colombo, Nicoletta
    Slomovitz, Brian
    Mirza, Mansoor Raza
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A193 - A193
12345